Active, not recruiting
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
NCT05176002
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +9 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China